4//SEC Filing
ALTMAN MICHAEL SETH 4
Accession 0001062993-24-012727
CIK 0001808805other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 6:03 PM ET
Size
5.5 KB
Accession
0001062993-24-012727
Insider Transaction Report
Form 4
ALTMAN MICHAEL SETH
DirectorChief Financial Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-06-14+45,000→ 45,000 totalExercise: $2.56Exp: 2034-06-14→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date.
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001746738
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 6:03 PM ET
- Size
- 5.5 KB